Table 2 Significant events during treatment
From: Treatment of anorexia nervosa with long-term risperidone in an outpatient setting: case study
Date | Weight (kg) | Event |
|---|---|---|
8/18/08 | 41.36 | First clinic visit |
9/11/08 | 39.32 | Inpatient treatment at an outside treatment facility (88 days) |
12/8/08 | 47.73 | Escitalopram 20 mg |
10/12/09 | 44.32 | Discontinued escitalopram, started sertraline 25 mg |
10/26/09 | 44.55 | Increased sertraline 50 mg |
11/30/09 | 44.55 | Increased sertraline 75 mg |
9/13/10 | 47.73 | Increased sertraline 100 mg |
11/1/10 | 47.36 | Increased sertraline 150 mg |
11/29/10 | 46.64 | Started risperidone 0.25 mg, continued sertraline 150 mg |
2/21/11 | 47.91 | Risperidone increased to 0.5 mg, continued sertraline 150 mg |
9/26/11 | 53.91 | Sertraline decreased to 100 mg, continued risperidone 0.5 mg |
12/5/11 | 54.09 | Restoration of menses |
4/27/12 | 52.09 | Last clinic visit |